FDA approves first epoetin alfa biosimilar for the treatment of anemia - FDA Press Releases

FDA approves Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia

from Food and Drug Administration--Press Releases https://ift.tt/2wFn9S8
via IFTTT